Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable' - 2Best Exciting ride: Which One Rushes You the Most?
- 3Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- 4Make your choice for the music application with the most amicable connection point!
- 5When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- The Best Web-based Courses for Ability Advancement
- Chemical leak in Oklahoma forces evacuations and leaves many ill
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- 5 Side interests That Work on Psychological wellness
- Vote In favor of Your Favored Kind Of Tea
- Hunger and makeshift shelters persist in north Caribbean nearly 2 months after Hurricane Melissa
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Monetary Freedom Guide: Plan Your Future
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
